LYRA
Lyra Therapeutics, Inc.Company with tickers: LYRA
CIK
1327273
CUSIP
55234L204
Shares Outstanding
1,774,882
13F Activity (30d)
3 filings
2 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-04-17 | 2026-04-13 | |
| 8-K | 2026-04-10 | 2026-03-31 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-16 | 2026-03-13 | |
| 8-K | 2026-02-27 | 2026-02-23 | |
| 8-K | 2026-02-06 | 2026-02-02 | |
| 8-K | 2026-01-12 | 2026-01-09 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-08-22 | 2025-08-20 | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-06-23 | 2025-06-13 | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-02 | 2025-05-27 | |
| 8-K | 2025-05-19 | 2025-05-14 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| 10-K | 2025-03-13 | 2024-12-31 | |
| 8-K | 2025-03-13 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-13 | 2024-12-12 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-07-23 | 2024-07-19 | |
| 8-K | 2024-06-18 | 2024-06-13 | |
| 8-K/A | 2024-06-07 | 2024-05-16 | |
| 8-K | 2024-05-21 | 2024-05-16 | |
| 8-K | 2024-04-30 | — | |
| 10-Q | 2024-04-30 | 2024-03-31 | |
| 8-K | 2024-04-19 | 2024-04-15 | |
| 10-K | 2024-03-22 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-03-01 | 2024-02-26 | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-12-28 | 2023-12-21 | |
| 8-K | 2023-12-18 | 2023-12-14 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-09-12 | — | |
| 8-K | 2023-09-01 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-07-14 | 2023-07-12 | |
| 8-K | 2023-06-15 | 2023-06-13 |
Showing 1–50 of 96 filings